MGLL and inflammatory bowel disease: The blockade of FAAH and MAGL enzymatic activity is considered a therapeutic target for neuropathic pain relief and may also alleviate inflammatory bowel diseases, anxiety, cancer metastasis, and Alzheimer's diseases (Figure 3) [65, 66].